161 related articles for article (PubMed ID: 5139315)
1. [Corticostesteroids in the treatment of scleroderma].
Szczepański A
Przegl Dermatol; 1971; 58(6):749-53. PubMed ID: 5139315
[No Abstract] [Full Text] [Related]
2. Treatment of the diseases of the dermis.
Polano MK
Arch Belg Dermatol Syphiligr; 1972; 28(1):59-73. PubMed ID: 4656306
[No Abstract] [Full Text] [Related]
3. [Treatment of scleroderma].
Wüthrich B
Schweiz Rundsch Med Prax; 1973 Sep; 62(38):1149-55. PubMed ID: 4148265
[No Abstract] [Full Text] [Related]
4. [The course of scleroderma following treatment with carnitin].
Nitzschner H
Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
[No Abstract] [Full Text] [Related]
5. [Prognosis and treatment of scleroderma].
Crickx B; Belaich S
Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
[TBL] [Abstract][Full Text] [Related]
6. [General and local hormonal therapy in scleroderma].
Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
[No Abstract] [Full Text] [Related]
7. Photochemotherapy for systemic and localized scleroderma.
De Rie MA; Bos JD
J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642
[No Abstract] [Full Text] [Related]
8. [Treatment of scleroderma with depolymerizing agents].
Konopík J; Krs V
Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
[No Abstract] [Full Text] [Related]
9. [Piascledine in the treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
[No Abstract] [Full Text] [Related]
10. [Treatment of some sclerosing processes with uropancreozymin].
Hodác V; Svatos A
Cesk Dermatol; 1971 Apr; 46(2):83-6. PubMed ID: 5564727
[No Abstract] [Full Text] [Related]
11. [Madecassol in the treatment of scleroderma (preliminary study)].
Szczepański A; Dabrowska H; Blaszczyk M
Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
[No Abstract] [Full Text] [Related]
12. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
Didenko IG
Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
[No Abstract] [Full Text] [Related]
13. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
Nitzschner H
Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
[No Abstract] [Full Text] [Related]
14. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
15. [Treatment of scleroderma].
Holzmann H; Korting GW; Morsches B
Actas Dermosifiliogr; 1971; 62(1):1-12. PubMed ID: 5158422
[No Abstract] [Full Text] [Related]
16. [Use of Tebessal in scleroderma].
Mattos O; de Oliveira Neto MP
Rev Bras Med; 1972 Mar; 29(3):139-40. PubMed ID: 5033154
[No Abstract] [Full Text] [Related]
17. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma].
Dovzhanskiĭ SI; Slesarenko NA
Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311
[No Abstract] [Full Text] [Related]
18. [Treatment of scleroderma and dermatomyositis in childhood].
Ansell BM
Clin Ter; 1978 Jan; 84(2):123-31. PubMed ID: 648095
[No Abstract] [Full Text] [Related]
19. Salazopyrin (azulfidine) treatment in scleroderma.
Dover N
Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
[No Abstract] [Full Text] [Related]
20. [Results of treatment of systemic lupus eruthematosus and diseminated circumscribed scleroderma with imuran].
Mazurkiewicz W; Blaszczyk M; Urbańska Z
Przegl Dermatol; 1969; 56(4):495-500. PubMed ID: 5354649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
